Which early-stage breast cancer patients who are candidates for 3-week hypofractionated whole breast EBRT are not good candidates for 1-week whole breast EBRT?

One important dosimetric criteria for 5.2 x 6 is V105 of 5% or less and v 107 of 2% or less.

For 3-week RT, our data suggest v105 < 10% caused less morbidity.

These dose homogeneity constraints are sometimes hard to meet for moderate or large size breasts, and one needs to be careful. Also, if a bo...

I agree with the answer above. My approach would be to continue to offer 5 fractions selectively during COVID (and after), when protocol-specified dosimetric constraints can be met. I have selectively used 5 fractions (per FAST or FAST-Forward) for a couple of years in appropriate circumstances, and...

While there are no clear strict criteria given the limited follow-up of FAST-Forward currently, I feel less comfortable offering FAST-Forward to women under 60. For those over 60, if appropriate, 5-fraction partial breast, I have been favoring over FAST-Forward, so I am not a heavy user of FAST-Forw...